MEI Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlights
–MEI Begins Fourth Fiscal Quarter with $169.0 Million in Cash– SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for the quarter ended March 31, 2022, and highlighted recent corporate events. “The third fiscal quarter of 2022 was underscored by a meeting with … [Read more…]
